GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » Price-to-Free-Cash-Flow

ZimVie (ZimVie) Price-to-Free-Cash-Flow : 19.86 (As of May. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ZimVie Price-to-Free-Cash-Flow?

As of today (2024-05-14), ZimVie's share price is $16.68. ZimVie's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.84. Hence, ZimVie's Price-to-Free-Cash-Flow Ratio for today is 19.86.

The historical rank and industry rank for ZimVie's Price-to-Free-Cash-Flow or its related term are showing as below:

ZIMV' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.14   Med: 21.03   Max: 150.85
Current: 20.02

During the past 6 years, ZimVie's highest Price-to-Free-Cash-Flow Ratio was 150.85. The lowest was 16.14. And the median was 21.03.

ZIMV's Price-to-Free-Cash-Flow is ranked better than
73.41% of 331 companies
in the Medical Devices & Instruments industry
Industry Median: 33.97 vs ZIMV: 20.02

ZimVie's Free Cash Flow per Share for the three months ended in Mar. 2024 was $-0.50. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.84.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of ZimVie was 588.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -20.10% per year.

During the past 6 years, ZimVie's highest 3-Year average Free Cash Flow per Share Growth Rate was -20.10% per year. The lowest was -59.30% per year. And the median was -39.70% per year.


ZimVie Price-to-Free-Cash-Flow Historical Data

The historical data trend for ZimVie's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Price-to-Free-Cash-Flow Chart

ZimVie Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - 19.05

ZimVie Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.26 - - 19.05 19.63

Competitive Comparison of ZimVie's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, ZimVie's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZimVie's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ZimVie's Price-to-Free-Cash-Flow falls into.



ZimVie Price-to-Free-Cash-Flow Calculation

ZimVie's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=16.68/0.84
=19.86

ZimVie's Share Price of today is $16.68.
ZimVie's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

ZimVie  (NAS:ZIMV) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


ZimVie Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ZimVie's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ZimVie (ZimVie) Business Description

Traded in Other Exchanges
Address
10225 Westmoor Drive, Westminster, CO, USA, 80021
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
Executives
Camber Capital Management Lp 10 percent owner 101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford director C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali director, officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc. 10 percent owner 345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz director MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar director 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec director C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider officer: Chief Accounting Officer C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021